Delta-8-THC

N/A

Report date: 2024/01/25 20:04:27
NME

Base Information

Drug NameDelta-8-THC
Drug Alias Namedelta-8-tetrahydrocannabinol
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor antagonists
TargetsCannabinoid receptor
Therapy Area/IndicationsCognition DisordersMotor DisordersAttention +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTeva Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Wisconsin-MadisonThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesNational Cancer InstituteTeva Branded Pharmaceutical Products R&D IncRafa Laboratories Ltd
Active IndicationsCognition DisordersMotor DisordersAttention +[4] 
Inactive IndicationsPeripheral Nervous System DiseasesColonic NeoplasmsBreast Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A